Invention Grant
- Patent Title: NAMPT inhibitors
-
Application No.: US13891357Application Date: 2013-05-10
-
Publication No.: US08975398B2Publication Date: 2015-03-10
- Inventor: Todd M. Hansen , Kenton Longenecker , Howard R. Heyman , Michael L. Curtin , Richard F. Clark , Bryan Sorensen , Zhiqin Ji , Kevin Woller , George Doherty , Robin Frey
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Glen J. Gesicki
- Main IPC: C07D401/00
- IPC: C07D401/00 ; C07D405/14 ; A61K31/4545 ; A61K31/496 ; A61K31/501 ; A61K31/5377 ; C07D409/14 ; C07D417/14 ; A61K31/506 ; C07D401/14 ; C07D401/04 ; C07D403/04 ; C07D403/14
Abstract:
Disclosed are compounds which inhibit the activity of NAMPT, compositions containing the compounds and methods of treating diseases during which NAMPT is expressed.
Public/Granted literature
- US20130303510A1 NAMPT INHIBITORS Public/Granted day:2013-11-14
Information query
